Samrat Pharmachem (BOM:530125) E10: ₹22.04 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530125 Samrat Pharmachem Ltd BOM:530125
63 GF Score
Price ₹247.85
GF Value ₹362.79
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Samrat Pharmachem E10?

Samrat Pharmachem BOM:530125 -0.04% 63 E10 is ₹22.04 as of Mar. 2026. GuruFocus rates BOM:530125 with a GF Score™ of 63/100 and a GF Value™ of ₹362.79 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Samrat Pharmachem's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹-6.590. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹22.04 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Samrat Pharmachem's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Samrat Pharmachem was 20.00% per year. The lowest was 6.50% per year. And the median was 13.25% per year.

As of today (2026-07-30), Samrat Pharmachem's current stock price is ₹247.85. Samrat Pharmachem's E10 for the quarter that ended in Mar. 2026 was ₹22.04. Samrat Pharmachem's Shiller PE Ratio of today is 11.25.

During the past 13 years, the highest Shiller PE Ratio of Samrat Pharmachem was 72.11. The lowest was 8.64. And the median was 20.47.


Samrat Pharmachem  (BOM:530125) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Samrat Pharmachem's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=247.85/22.04
=11.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Samrat Pharmachem was 72.11. The lowest was 8.64. And the median was 20.47.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Samrat Pharmachem E10 Related Terms


Samrat Pharmachem E10 Historical Data

* Premium members only.

The historical data trend for Samrat Pharmachem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Samrat Pharmachem E10 Chart

Samrat Pharmachem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.91 18.26 19.61 22.32 22.04

Samrat Pharmachem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.32 22.52 22.67 22.65 22.04

BOM:530125 vs DOW: E10 Comparison

For the Chemicals subindustry, Samrat Pharmachem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samrat Pharmachem Shiller PE Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Samrat Pharmachem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Samrat Pharmachem's Shiller PE Ratio falls into.


BOM:530125
63GF Score
Samrat Pharmachem Ltd BOM:530125
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Samrat Pharmachem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Samrat Pharmachem's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-6.59/164.2724*164.2724
=-6.590

Current CPI (Mar. 2026) = 164.2724.

Samrat Pharmachem Quarterly Data

per share eps CPI Adj_EPS
201606 0.810 105.961 1.256
201609 1.630 105.961 2.527
201612 2.040 105.196 3.186
201703 1.210 105.196 1.890
201706 1.930 107.109 2.960
201709 1.650 109.021 2.486
201712 4.560 109.404 6.847
201803 2.270 109.786 3.397
201806 0.140 111.317 0.207
201809 -0.290 115.142 -0.414
201812 0.920 115.142 1.313
201903 4.210 118.202 5.851
201906 6.050 120.880 8.222
201909 4.860 123.175 6.482
201912 1.520 126.235 1.978
202003 1.270 124.705 1.673
202006 2.580 127.000 3.337
202009 4.660 130.118 5.883
202012 4.970 130.889 6.238
202103 5.050 131.771 6.296
202106 3.090 134.084 3.786
202109 9.030 135.847 10.919
202112 20.870 138.161 24.814
202203 22.640 138.822 26.791
202206 30.320 142.347 34.990
202209 19.140 144.661 21.735
202212 6.780 145.763 7.641
202303 -2.410 146.865 -2.696
202306 1.980 150.280 2.164
202309 -0.610 151.492 -0.661
202312 1.110 152.924 1.192
202403 4.520 153.035 4.852
202406 6.690 155.789 7.054
202409 8.610 157.882 8.958
202412 9.010 158.323 9.349
202503 -1.290 157.552 -1.345
202506 -0.740 159.755 -0.761
202509 -1.900 162.289 -1.923
202512 -1.490 163.281 -1.499
202603 -6.590 164.272 -6.590

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹22.04 mean?
Samrat Pharmachem (BOM:530125) has a E10 of ₹22.04 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Samrat Pharmachem and its competitors.
Is Samrat Pharmachem's E10 too high?
Samrat Pharmachem's current E10 is ₹22.04. Overall, Samrat Pharmachem has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's E10 compare to DOW?
Samrat Pharmachem's E10 of ₹22.04 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Chemicals company?
A good E10 depends on the Chemicals industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Samrat Pharmachem and its competitors. Samrat Pharmachem's current E10 is ₹22.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹362.79, compared to a current price of ₹247.85 — trading 31.7% below its estimated fair value. The current E10 is ₹22.04. Samrat Pharmachem's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current E10 is ₹22.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?

Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued. The current stock price of ₹247.85 is trading 31.7% below its estimated GF Value™ of ₹362.79. GuruFocus considers Samrat Pharmachem to be Significantly Undervalued.

Key valuation signals for BOM:530125:

  • E10: ₹22.04
  • GF Value™: ₹362.79 vs. price of ₹247.85 (31.7% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Samrat Pharmachem Business Description

Address M. A. Road, 701/702, Business Square, Andheri (West), Mumbai, MH, IND, 400 058
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
63GF Score

Get the complete analysis for BOM:530125

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹247.85
Price
₹362.79
GF Value